128 related articles for article (PubMed ID: 16198980)
1. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study.
Höckel M; Horn LC; Fritsch H
Lancet Oncol; 2005 Oct; 6(10):751-6. PubMed ID: 16198980
[TBL] [Abstract][Full Text] [Related]
2. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis.
Höckel M; Horn LC; Manthey N; Braumann UD; Wolf U; Teichmann G; Frauenschläger K; Dornhöfer N; Einenkel J
Lancet Oncol; 2009 Jul; 10(7):683-92. PubMed ID: 19482513
[TBL] [Abstract][Full Text] [Related]
3. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
4. Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology.
Höckel M
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S106-12. PubMed ID: 17727931
[TBL] [Abstract][Full Text] [Related]
5. Local spread of cervical cancer revisited: a clinical and pathological pattern analysis.
Höckel M; Kahn T; Einenkel J; Manthey N; Braumann UD; Hildebrandt G; Leo C; Hentschel B; Vaupel P; Horn LC
Gynecol Oncol; 2010 Jun; 117(3):401-8. PubMed ID: 20236693
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.
Höckel M; Wolf B; Schmidt K; Mende M; Aktas B; Kimmig R; Dornhöfer N; Horn LC
Lancet Oncol; 2019 Sep; 20(9):1316-1326. PubMed ID: 31383547
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
Atasii T; Aksu MF; Cetinkaya MB
Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
10. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
11. Total mesometrial resection: high resolution nerve-sparing radical hysterectomy based on developmentally defined surgical anatomy.
Höckel M; Horn LC; Hentschel B; Höckel S; Naumann G
Int J Gynecol Cancer; 2003; 13(6):791-803. PubMed ID: 14675316
[TBL] [Abstract][Full Text] [Related]
12. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
13. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
Hille A; Weiss E; Hess CF
Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
[TBL] [Abstract][Full Text] [Related]
18. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
[TBL] [Abstract][Full Text] [Related]
19. [Oncological outcomes of combined therapy in patients with cervical carcinoma FIGO stage IIB].
Kornovski Y; Ismail E; Kaneva M
Akush Ginekol (Sofiia); 2012; 51(4):24-9. PubMed ID: 23234022
[TBL] [Abstract][Full Text] [Related]
20. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
